1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Atomoxetine restores the response inhibition network in Parkinson's disease
- Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
- A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment
- 2015
- Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
- Improving response inhibition in Parkinson's disease with atomoxetine
- 2014
- Targeting impulsivity in Parkinson's disease using atomoxetine
- Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease
- Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease : ICICLE-PD study
- Characterizing mild cognitive impairment in incident Parkinson disease : the ICICLE-PD study
- 2013
- The CamPaIGN study of Parkinson's disease : 10-year outlook in an incident population-based cohort